A Manganese-Superoxide Dismutase From Thermus thermophilus HB27 Suppresses Inflammatory Responses and Alleviates Experimentally Induced Colitis. Issue 10 (8th May 2019)
- Record Type:
- Journal Article
- Title:
- A Manganese-Superoxide Dismutase From Thermus thermophilus HB27 Suppresses Inflammatory Responses and Alleviates Experimentally Induced Colitis. Issue 10 (8th May 2019)
- Main Title:
- A Manganese-Superoxide Dismutase From Thermus thermophilus HB27 Suppresses Inflammatory Responses and Alleviates Experimentally Induced Colitis
- Authors:
- Sheng, Yang
Li, Hailong
Liu, Minjun
Xie, Bingxian
Wei, Wen
Wu, Jiawei
Meng, Fanguo
Wang, Hong Yu
Chen, Shuai - Abstract:
- Abstract: Background: Superoxide dismutase (SOD) is an attractive therapeutic agent to ameliorate oxidative stress that is critical for the initiation and progression of inflammatory bowel disease (IBD). However, the short life of SOD limits its clinical application. In this study, we aim to examine the therapeutic effects of a hyperthermostable SOD from the Thermus thermophilus HB27 (TtSOD) for treatment of experimentally induced IBD. Methods: A recombinant TtSOD was expressed and purified from Escherichia coli, and its therapeutic effects were examined in 2 experimental IBD animal models. Results: In IBD induced by 2, 4, 6-trinitrobenzenesulfonic acid in zebrafish, TtSOD treatment decreased intestinal enlargement and attenuated neutrophil infiltration, resulting in alleviation of enterocolitis. In mice, SOD activity was substantially increased in the intestine after oral gavage of TtSOD, which ameliorated gut inflammation, preserved gut barrier function, and attenuated the severity of dextran sulfate sodium–induced colitis. Furthermore, TtSOD inhibited lipopolysaccharide-induced production of reactive oxygen species and inflammatory responses in mouse bone marrow–derived macrophages. Conclusions: Our results demonstrate that TtSOD possesses therapeutic activities toward experimentally induced IBD, offering new clinical treatment options for patients with IBD. Abstract : A hyperthermostable SOD from the Thermus thermophilus HB27 (TtSOD) alleviated experimentally-inducedAbstract: Background: Superoxide dismutase (SOD) is an attractive therapeutic agent to ameliorate oxidative stress that is critical for the initiation and progression of inflammatory bowel disease (IBD). However, the short life of SOD limits its clinical application. In this study, we aim to examine the therapeutic effects of a hyperthermostable SOD from the Thermus thermophilus HB27 (TtSOD) for treatment of experimentally induced IBD. Methods: A recombinant TtSOD was expressed and purified from Escherichia coli, and its therapeutic effects were examined in 2 experimental IBD animal models. Results: In IBD induced by 2, 4, 6-trinitrobenzenesulfonic acid in zebrafish, TtSOD treatment decreased intestinal enlargement and attenuated neutrophil infiltration, resulting in alleviation of enterocolitis. In mice, SOD activity was substantially increased in the intestine after oral gavage of TtSOD, which ameliorated gut inflammation, preserved gut barrier function, and attenuated the severity of dextran sulfate sodium–induced colitis. Furthermore, TtSOD inhibited lipopolysaccharide-induced production of reactive oxygen species and inflammatory responses in mouse bone marrow–derived macrophages. Conclusions: Our results demonstrate that TtSOD possesses therapeutic activities toward experimentally induced IBD, offering new clinical treatment options for patients with IBD. Abstract : A hyperthermostable SOD from the Thermus thermophilus HB27 (TtSOD) alleviated experimentally-induced colitis in animal models. TtSOD exerted its therapeutic effects at least in part through decreasing reactive oxygen species in macrophages and thereby ameliorating inflammatory responses. … (more)
- Is Part Of:
- Inflammatory bowel diseases. Volume 25:Issue 10(2019)
- Journal:
- Inflammatory bowel diseases
- Issue:
- Volume 25:Issue 10(2019)
- Issue Display:
- Volume 25, Issue 10 (2019)
- Year:
- 2019
- Volume:
- 25
- Issue:
- 10
- Issue Sort Value:
- 2019-0025-0010-0000
- Page Start:
- 1644
- Page End:
- 1655
- Publication Date:
- 2019-05-08
- Subjects:
- SOD -- inflammatory bowel disease -- colitis -- inflammation -- macrophage
Inflammatory bowel diseases -- Periodicals
Colitis, Ulcerative -- Periodicals
Crohn Disease -- Periodicals
Inflammatory Bowel Diseases -- Periodicals
616.344 - Journal URLs:
- http://journals.lww.com/ibdjournal/pages/default.aspx ↗
http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1536-4844/ ↗
http://ovidsp.ovid.com/ovidweb.cgi?T=JS&NEWS=n&CSC=Y&PAGE=toc&D=ovft&AN=00054725-000000000-00000 ↗
https://academic.oup.com/ibdjournal ↗
http://journals.lww.com ↗ - DOI:
- 10.1093/ibd/izz097 ↗
- Languages:
- English
- ISSNs:
- 1078-0998
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 4478.845400
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 16943.xml